These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 21567380)

  • 1. Mortality bias in reporting cancer incidence in disease registries: comment on the article by Chen et al.
    Yazici H; Tascilar K; Kiroglu G; Erar A; Duransoy ML
    Arthritis Rheum; 2011 Aug; 63(8):2543-4; author reply 2544. PubMed ID: 21567380
    [No Abstract]   [Full Text] [Related]  

  • 2. Large Study But Weak Test of Internal Validation: Comment on the Article by Solomon et al.
    Collins GS; Le Manach Y
    Arthritis Rheumatol; 2015 Dec; 67(12):3327. PubMed ID: 26316319
    [No Abstract]   [Full Text] [Related]  

  • 3. The influence of sex on the frequency of erosive disease and extraarticular manifestations in rheumatoid arthritis: comment on the article by Weyand et al.
    Alarcón GS
    Arthritis Rheum; 1999 Mar; 42(3):587; author reply 589-90. PubMed ID: 10088790
    [No Abstract]   [Full Text] [Related]  

  • 4. Rheumatoid arthritis and diabetes mellitus: Two faces of one coin? Comment on the article by Peters et al.
    Vizzardi E; Cavazzana I; Franceschini F; Tincani A; Dei Cas L
    Arthritis Care Res (Hoboken); 2010 Aug; 62(8):1201-2; author reply 1202. PubMed ID: 20506123
    [No Abstract]   [Full Text] [Related]  

  • 5. Assessing cognitive function in rheumatoid arthritis: comment on the article by Shin et al.
    Meade T; Manolios N
    Arthritis Care Res (Hoboken); 2013 Aug; 65(8):1390. PubMed ID: 23509027
    [No Abstract]   [Full Text] [Related]  

  • 6. Sex-associated factors and the presentation of rheumatoid arthritis: comment on the article by Weyand et al.
    Saraux A; Guedes C; Belghomari H; Youinou P; Le Goff P
    Arthritis Rheum; 1999 Mar; 42(3):588-90. PubMed ID: 10088791
    [No Abstract]   [Full Text] [Related]  

  • 7. Response to: 'Comorbidities in a Mexican mestizo cohort with established rheumatoid arthritis' by Vega-Morales et al.
    Dougados M
    Ann Rheum Dis; 2014 Mar; 73(3):e15. PubMed ID: 24336333
    [No Abstract]   [Full Text] [Related]  

  • 8. Vitamin D deficiency does not increase the risk of rheumatoid arthritis: comment on the article by Merlino et al.
    Nielen MM; van Schaardenburg D; Lems WF; van de Stadt RJ; de Koning MH; Reesink HW; Habibuw MR; van der Horst-Bruinsma IE; Twisk JW; Dijkmans BA
    Arthritis Rheum; 2006 Nov; 54(11):3719-20. PubMed ID: 17075887
    [No Abstract]   [Full Text] [Related]  

  • 9. Is there an association between anti-TNF monoclonal antibody therapy in rheumatoid arthritis and risk of malignancy and serious infection? Commentary on the meta-analysis by Bongartz et al.
    Dixon W; Silman A
    Arthritis Res Ther; 2006; 8(5):111. PubMed ID: 16911768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Rheumatoid arthritis and neoplasms].
    Duquesnoy B; Flipo RM
    Rev Rhum Ed Fr; 1994 Dec; 61(10 Pt 2):194S-197S. PubMed ID: 7858571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is decaf a decoy? Comment on the article by Mikuls et al.
    Bazzi A; Portnoff K; Pischel KD
    Arthritis Rheum; 2003 Mar; 48(3):862. PubMed ID: 12632452
    [No Abstract]   [Full Text] [Related]  

  • 12. How comparable are rates of malignancies in patients with rheumatoid arthritis across the world? A comparison of cancer rates, and means to optimise their comparability, in five RA registries.
    Askling J; Berglind N; Franzen S; Frisell T; Garwood C; Greenberg JD; Ho M; Holmqvist M; Horne L; Inoue E; Michaud K; Nyberg F; Pappas DA; Reed G; Tanaka E; Tran TN; Verstappen SM; Yamanaka H; Wesby-van Swaay E; Symmons D
    Ann Rheum Dis; 2016 Oct; 75(10):1789-96. PubMed ID: 26621482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Therapy of rheumatoid arthritis: what influences the risk of infections and malignant neoplasms?].
    Fiehn C
    Dtsch Med Wochenschr; 2014 Feb; 139(6):268-71. PubMed ID: 24473846
    [No Abstract]   [Full Text] [Related]  

  • 14. The risk of cancer in patients with rheumatoid arthritis: a nationwide cohort study in Taiwan.
    Chen YJ; Chang YT; Wang CB; Wu CY
    Arthritis Rheum; 2011 Feb; 63(2):352-8. PubMed ID: 21279991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival of cancer in patients with rheumatoid arthritis: a follow-up study in Sweden of patients hospitalized with rheumatoid arthritis 1 year before diagnosis of cancer.
    Ji J; Liu X; Sundquist K; Sundquist J
    Rheumatology (Oxford); 2011 Aug; 50(8):1513-8. PubMed ID: 21498553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rheumatoid arthritis as seen from official data registers. Experience in Finland.
    Isomäki HA
    Scand J Rheumatol Suppl; 1989; 79():21-4. PubMed ID: 2595334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comment on: prevalence and incidence of rheumatoid arthritis in southern Sweden 2008 and their relation to prescribed biologics.
    Chodick G
    Rheumatology (Oxford); 2010 Oct; 49(10):1999-2000; author reply 2000. PubMed ID: 20634229
    [No Abstract]   [Full Text] [Related]  

  • 18. Incidence of vasculitis in rheumatoid arthritis: comment on the article by Turesson et al.
    Puéchal X
    Arthritis Rheum; 2005 May; 52(5):1620; author reply 1621. PubMed ID: 15880350
    [No Abstract]   [Full Text] [Related]  

  • 19. Does cancer that occurs during or after anti-tumor necrosis factor therapy have a worse prognosis? A national assessment of overall and site-specific cancer survival in rheumatoid arthritis patients treated with biologic agents.
    Raaschou P; Simard JF; Neovius M; Askling J;
    Arthritis Rheum; 2011 Jul; 63(7):1812-22. PubMed ID: 21305513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Oslo experience with arthritis registries.
    Kvien TK; Uhlig T
    Clin Exp Rheumatol; 2003; 21(5 Suppl 31):S118-22. PubMed ID: 14969062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.